Curiox Biosystems

In 2010, Curiox received a large corporate investment by the Zicom Group, a Singaporean/ Australian conglomerate listed on the Australian Stock Exchange. Spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore, Curiox brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation with the goal of overcoming critical challenges that slow the pace of life science research. Become part of a world leading science and engineering team that invests in the future of its employees and the success of our customers. IMM Investment is one of the leading native Korea investment firm, focusing on venture capital, mezzanine, infrastructure and aircraft investments. IMM AUM has built up to USD 3.7bn, and has accumulated Exit IRR of 23.8%. Mr Sim is a founder of Zicom Holdings Pte Ltd in 1978 and was appointed to the board on 5 April 1995. David Choiniere brings over 25 years of experience in the life sciences market, with extensive experience in flow cytometry, drug discovery, high throughput screening, and immunotherapy. Namyong Kim brings with him more than 15 years of experiences in scientific research and technical management in the development of biotech instrumentation.